Диссертация (1139884), страница 17
Текст из файла (страница 17)
Бшарат Х.А. Отдалённые результаты и качество жизни послерадиочастотной процедуры «MAZE» у пациентов с фибрилляциейпредсердий: Автореф. дис. кандидата мед. наук. - Томск, 2007 - 87 с.3. ВознюкО.А.предсердийвКлиническиеособенностизависимостиоттечениявыраженностифибрилляциитревожныхидепрессивных расстройств и их медикаментозной коррекции: Дисс. …кандидата мед. наук.- Оренбург, 2008, - 24 с.4. Дедов Д.В., Иванов А.П., Эльгард И.А..
Риск рецидива фибрилляциипредсердий у больных ишемической болезнью сердца и артериальнойгипертензиейподаннымхолтеровскогомониторированияэлектрокардиограммы // Вестник аритмологии. - 2010. - №59. - С. 2732.5. Дроздов И., Ганеева О., Амирасланов А., Александров А., Книгин А.,Коков Л. Качество жизни больных с фибрилляцией предсердий послерадиочастотной абляции атриовентрикулярного соединения // Врач. 2009. - С. 72-73.6. Железнев С.И., Богачёв-Прокофьев А.В., Назаров В.М., Пивкин А.Н.,Музаев В.Р. Отдалённые результаты хирургической процедуры Maze упациентов с клапанной патологией и фибрилляцией предсердий //Патология кровообращения и кардиохирургия.
- 2011.- (3). - С. 17-21.7. Ломакин В.В, Копылов Ф.Ю., Никитина Ю.М., Смулевич А.Б., СыркинА.Л..Психосоматическиеособенноститеченияфибрилляции108предсердий // Кардиология и сердечно-сосудистая хирургия. - 2009. № 1. - С. 61-65.8. Медик, В.А. Общественное здоровье и здравоохранение / В.А. Медик,В.К. Юрьев.- М.: Профессионал, 2009.- 432 с.9. Новик А.А., Ионова Т.И.
Руководство по исследованию качества жизнив медицине. С-Пб.: Олма-пресс,2002. - 320 с.10. ОгановР.Г.,ОльбинскаяЛ.И.,СмулевичА.Б.Депрессииирасстройства депрессивного спектра в общемедицинской практике.Результаты программы КОМПАС. Кардиология. 2004;1:48-54.11. Яковенко ТВ, Шубик ЮВ, Костюк ГП, Крятова ТВ и соавт. Качествожизни пациентов с различными формами фибрилляции предсердий ивлияние на него лечения нозогенных психических реакций // ВестникАримологии.
- 2008, №51. - С. 36-39.12.Ahern DK, Gorkin L, Anderson JL, et al. Biobehavioral variables andmortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS).Am J Cardiol 1990; 66:59–62.13.Almeida GQ, Noblat L de A, Passos LC, do Nascimento HF. Quality of lifeanalysis of patients in chronic use of oral anticoagulant: an observationalstudy. Health Qual Life Outcomes. 2011 Oct 25;9:91.14.Ansell J, Hirsh J, Hylek E, et al.
Pharmacology and management of thevitamin K antagonists: American College of Chest Physicians EvidenceBased Clinical Practice Guidelines (8th Edition). Chest. 2008; 133(6Suppl):160S–198S.15.Ariansen I, Dammen T, Abdelnoor M, Tveit A, Gjesdal K. Mental Healthand Sleep in Permanent Atrial Fibrillation Patients From the GeneralPopulation. Clin. Cardiol. 34, 5, 327–331 (2011).16.Ariansen I, Dammen T, Abdelnoor M, Tveit A, Gjesdal K. Mental healthand sleep in permanent atrial fibrillation patients from the generalpopulation. Clin Cardiol.
2011 May;34(5):327-31. doi: 10.1002/clc.20883.Epub 2011 Feb 11.10917.Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, LevyD. Impact of atrial fibrillation on the risk of death: the Framingham HeartStudy. Circulation 1998; 98: 946–52.18.Berry C, Stewart S, Payne EM, McArthur JD, McMurray JJ. Electricalcardioversion for atrial fibrillation: Outcomes in “real-life” clinical practice.Int J Cardiol 2001;81:29–35.19.Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect ofradiofrequency catheter ablation on health-related quality of life andactivities of daily living in patients with recurrent arrhythmias. Circulation1996;94:1585–1591.20.Bubien RS, Sanchez JE. Atrial fibrillation: treatment rationale and clinicalutility of nonpharmacologic therapies.
AACN Clin Issues 2001;12:140–55.21.Camm AJ, Breithardt G, Crijns H, Dorian P, Kowey P, Le Heuzey JY,Merioua I, Pedrazzini L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C,Weintraub W. Real-life observations of clinical outcomes with rhythm- andrate-control therapies for atrial fibrillation RECORDAF (Registry onCardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). JAm Coll Cardiol. 2011 Jul 26;58(5):493-501.22.Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management ofatrial Fibrillation. The Task Force for the Management of Atrial Fibrillationof the European Society of Cardiology (ESC). European Heart Journal(2010) 31, 2369–2429.23.Camm AJ.
Quality of Life in Patients With Atrial Fibrilation. Rev EspCardiol. 2010;63(12):1393-5.24.Carlsson, Jo; Miketic, S.; Windeler, Ju; Cuneo, A.; Haun, S.; Micus, S.;Walter, S.; Tebbe, U.; Investigators, S. Randomized trial of rate-controlversus rhythm-control in persistent atrial fibrillation: The Strategies ofTreatment of Atrial Fibrillation (STAF) study.
J Am Coll Cardiol2003;41:1690–1696.11025.Charúa-Guindic L, Benavides-León CJ, Villanueva-Herrero JA, JiménezBobadilla B, Abdo-Francis JM, Hernández-Labra E. Quality of life inostomized patients. Cir Cir. 2011 Mar-Apr;79(2):149-55.26.Chen MS, Marrouche NF, Khaykin Y, Gillinov AM, Wazni OM, MartinDO, Rossillo A, Verma A, Cummings J, Erciyes D, Saad E, Bhargava M,Bash D, Schweikert R, Burkhardt D, Williams-Andrews M, Perez-LugonesA, Abdul-Karim A, Salib W, Natale A. Pulmonary vein isolation for thetreatment of atrial fibrillation in patients with impaired systolic function. JAm Coll Cardiol 2004;43:1004–100927.Cherr GS, Zimmerman PM, Wang J, Dosluoglu HH. Patients withdepression are at increased risk for secondary cardiovascular events afterlower extremity revascularization.
J Gen Intern Med. 2008 May;23(5):62934.28.Corbi ISA, Dantas RAS, Pelegrino FM, Carvalho ARS.Health relatedquality of life of patients undergoing oral anticoagulation therapy. Rev.Latino-Am. Enfermagem 2011 July-Aug.;19(4):865-73.29.Cuijpers P, van Lammeren P. Secondary prevention of depressive symptomsin elderly inhabitants of residential homes. Int J Geriatr Psychiatry. 2001Jul;16(7):702-8.30.Dąbrowski R, Smolis−Bąk E, Kowalik I, Kazimierska B, Wójcicka M,Szwed H. Quality of life and depression in patients with different patterns ofatrial fibrillation. Kardiol Pol 2010; 68, 10: 1133–1139.31.Dantas GC, Thompson BV, Manson JA, Tracy CS, Upshur RE.
Patients’perspectives on taking warfarin: qualitative study in family practice. BMCFam Pract. 2004;5:15.32.Das AK, Ahmed A, Corrado OJ, West RM. Quality of life of elderly peopleon warfarin for atrial fibrillation. Age Ageing. 2009;38: 751–754.33.Das AK, Willcoxson PD, Corrado OJ, West RM. The impact of long-termwarfarin on the quality of life of elderly people with atrial fibrillation. AgeAgeing. 2007;36(1):95–97.11134.Davis NJ, Billett HH, Cohen HW, Arnsten JH. Impact of adherence,knowledge, and quality of life on anticoagulation control.AnnPharmacother. 2005;39(4):632–636.35.Dorian P, Cvitkovic SS, Kerr CR, et al.
A novel, simple scale for assessingthe symptom severity of artrial fibrillation at the bedside: The CCS SAFscale. Can J Cardiol. 2006; 22: 383-6.36.Dorian P, Jung W, Newman D, et al. The impairment of health-relatedquality of life in patients with intermittent atrial fibrillation: implications forthe assessment of investigational therapy J. Am. Coll.
Cardiol.2000;36;1303-9.37.Dorian P, Paquette M, Newman D, Green M, Connolly SJ, Talajic M, RoyD. Quality of life improves with treatment in the Canadian Trial of AtrialFibrillation. Am Heart J 2002;143:984–990.38.Dorian P, Ha AC. Does better rate control improve quality of life? Be stillmy beating heart. J Am Coll Cardiol. 2011 Oct 18;58(17):1804-6.39.Engelmann MDM, Pehrson S. Quality of life in nonpharmacologic treatmentof atrial fibrillation.
European Heart Journal (2003) 24, 1387–1400.40.Erdogan A, Carlsson J, Neumann T, Berkowitsch A, Neuzner J, Hamm CW,Pitschner HF. Qualityof-life in patients with paroxysmal atrial fibrillationafter catheter ablation: Results of long-term follow-up. Pacing ClinElectrophysiol 2003;26:678–684.41.Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG.Prevalence, age distribution, and gender of patients with atrial fibrillation.Analysis and implications. Arch Intern Med 1995; 155: 469–73.42.Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Qualityof life measures in health care, I: applications and issues in assessment.BMJ.
1992;305:1074-1077.43.Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M,Barrell P. Asymptomatic atrial fibrillation: Demographic features and112prognostic information from the Atrial Fibrillation Follow-up Investigationof Rhythm Management (AFFIRM) study. Am Heart J 2005;149:657–663.44.Fletcher A, Gore S, Jones D et al. Quality of life measures in health care. II:Design, analysis, and interpretation. BMJ 1992;305:1145–8.45.Frasure-Smith N, Lespérance F, Habra M, Talajic M, Khairy P, Dorian P,Roy D; Atrial Fibrillation and Congestive Heart Failure Investigators.Elevated depression symptoms predict long-term cardiovascular mortality inpatients with atrial fibrillation and heart failure. Circulation.
2009 Jul14;120(2):134-40, 3p following 140.46.Frasure-Smith N, Lesperance F, Juneau M, et al. Gender, depression, andone-year prognosis after myocardial infarction. Psychosom Med 1999;61:26–37.47.Frasure-Smith N, Lespérance F, Talajic M, Khairy P, Dorian P, O'Meara E,Roy D. Anxiety sensitivity moderates prognostic importance of rhythmcontrol versus rate-control strategies in patients with atrial fibrillation andcongestive heart failure: insights from the Atrial Fibrillation and CongestiveHeart Failure Trial.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
